{
  "html_url": "https://licitia.com.mx/adjudicacion/aa-11-l4j-011l4j999-n-321-2023",
  "canonical": "https://licitia.com.mx/adjudicacion/aa-11-l4j-011l4j999-n-321-2023",
  "id": "b3e6ec285064487a8e29723b97bdf289",
  "procedure_number": "AA-11-L4J-011L4J999-N-321-2023",
  "file_number": "E-2023-00071341",
  "title": "AUDITORIA DE PROYECTO CONACYT (FOINS) 5098",
  "description": {
    "short": "Adquisiciones, arrendamientos y servicios, dentro de los montos máximos establecidos en el PEF.",
    "detailed": "AUDITORIA DEL PROYECTO CONACYT (FOINS)5098\nMECANISMOS DE MODULACION DEL DOLOR NUROPATICO INDUCIDO POR DIABETES: EL RECEPTOR ALFA 5 GABAA COMO UN BLANCO FARMACOLOGICO PARA TRATAR LA NEUROPATIA DIABETICA"
  },
  "lifecycle": {
    "section": "concluido",
    "source_status": "ADJUDICADO",
    "moved_at": null
  },
  "buyer": {
    "agency": "CENTRO DE INVESTIGACION Y DE ESTUDIOS AVANZADOS DEL INSTITUTO POLITECNICO NACIONAL",
    "acronym": "CINVESTAV",
    "branch": "11 - EDUCACIÓN PÚBLICA",
    "buying_unit": "SUBDIRECCION DE RECURSOS MATERIALES",
    "requesting_unit": "unidad requiriente data",
    "requesting_group": "SUBDIRECCION DE RECURSOS MATERIALES",
    "entity": null,
    "slug": "cinvestav"
  },
  "classification": {
    "procedure_type": "ADJUDICACIÓN DIRECTA",
    "contracting_type": "SERVICIOS",
    "publication_type": null,
    "character": "NACIONAL",
    "fiscal_year": 2023,
    "law": "LEY DE ADQUISICIONES, ARRENDAMIENTOS Y SERVICIOS DEL SECTOR PÚBLICO",
    "legal_basis_id": "42",
    "exception_basis": "Art. 42 párrafo primero",
    "internal_control_number": "REQUISICION 6076",
    "supply_source_number": null
  },
  "schedule": {
    "published_at": "2023-08-09T22:19:22.000Z",
    "clarification_meeting_at": null,
    "clarification_questions_deadline_at": null,
    "clarification_responses_deadline_at": null,
    "bid_opening_at": "2023-08-10T16:00:00.000Z",
    "award_at": null,
    "estimated_contract_at": "2023-08-11T06:00:00.000Z",
    "site_visit_at": null,
    "estimated_work_start_at": null
  },
  "estimated_value": {
    "minimum": null,
    "maximum": null,
    "currency": "MXN",
    "updated_at": null
  },
  "lots": [
    {
      "number": "1",
      "name": "PARTIDA SOLA",
      "description": "PARTIDA SOLA",
      "requirement_group_id": "1",
      "items": [
        {
          "number": "1",
          "cucop_code": "33104-0001",
          "specific_item_code": "33104",
          "cucop_description": "ASESORIA EN ASPECTOS JURIDICOS DEL PROCESO DE REESTRUCTURACION Y MODERNIZACION DEL SECTOR ENERGETICO",
          "description": "AUDITORIA DEL PROYECTO CONACYT (FOINS)5098\nMECANISMOS DE MODULACION DEL DOLOR NUROPATICO INDUCIDO POR DIABETES: EL RECEPTOR ALFA 5 GABAA COMO UN BLANCO FARMACOLOGICO PARA TRATAR LA NEUROPATIA DIABETICA",
          "requested_quantity": "1",
          "minimum_quantity": "1",
          "maximum_quantity": null,
          "unit": "SERVICIO",
          "minimum_amount": null,
          "maximum_amount": null
        }
      ]
    }
  ],
  "awards": [
    {
      "id": "C-2023-00089910",
      "internal_reference": "3958",
      "title": "AUDITORIA DE PROYECTO CONACYT (FOINS) 5098",
      "status": "PUBLICADO",
      "contractor": {
        "name": "GOSSLER SC",
        "normalized_name": "GOSSLER",
        "rfc_type": null,
        "slug": "gossler"
      },
      "contract_period": {
        "published_at": "2023-08-11T17:00:50.000Z",
        "starts_at": "2023-08-11T06:00:00.000Z",
        "ends_at": "2023-12-14T06:00:00.000Z"
      },
      "value": {
        "subtotal": "17500",
        "tax": "2800",
        "total": "20300",
        "maximum_subtotal": "0",
        "maximum_total": "0",
        "currency": "MXN"
      },
      "open_contract_type": null,
      "quantity": null,
      "exercised_quantity": null,
      "participants": [],
      "line_items": [
        {
          "number": "0",
          "cucop_code": "33104-0001",
          "description": "AUDITORIA DEL PROYECTO CONACYT (FOINS)5098\nMECANISMOS DE MODULACION DEL DOLOR NUROPATICO INDUCIDO POR DIABETES: EL RECEPTOR ALFA 5 GABAA COMO UN BLANCO FARMACOLOGICO PARA TRATAR LA NEUROPATIA DIABETICA",
          "unit": "SERVICIO",
          "requested_quantity": "1",
          "awarded_quantity": null,
          "unit_price": "17500",
          "subtotal": "17500",
          "tax": "2800",
          "other_taxes": null,
          "total": "20300"
        }
      ]
    }
  ],
  "documents": [
    {
      "id": null,
      "annex_number": 1,
      "document_type": null,
      "description": "SOLICITUD DE COTIZACIÓN",
      "filename": "SUFICIENCIA PRES.pdf",
      "availability": "available",
      "size_bytes": "221870",
      "mime_type": "application/pdf",
      "sha256": null,
      "uploaded_at": "2025-12-07T22:26:59.187Z",
      "updated_at": "2025-12-07T22:26:59.188Z"
    },
    {
      "id": null,
      "annex_number": 2,
      "document_type": null,
      "description": "ANEXO TÉCNICO",
      "filename": "COT.pdf",
      "availability": "available",
      "size_bytes": "640846",
      "mime_type": "application/pdf",
      "sha256": null,
      "uploaded_at": "2025-12-07T22:27:01.942Z",
      "updated_at": "2025-12-07T22:27:01.944Z"
    },
    {
      "id": null,
      "annex_number": 4,
      "document_type": null,
      "description": "OFICIO DE ADJUDICACIÓN",
      "filename": "20230811122141016.pdf",
      "availability": "available",
      "size_bytes": "313856",
      "mime_type": "application/pdf",
      "sha256": null,
      "uploaded_at": "2025-12-07T22:27:03.559Z",
      "updated_at": "2025-12-07T22:27:03.561Z"
    }
  ],
  "alternates": [],
  "similar": [
    {
      "numero_procedimiento": "aa-11-l4j-011l4j999-n-276-2025",
      "nombre_procedimiento": "R 134 SERVICIO DE AUDITORIA CORRESPONDIENTE AL PROYECTO PRONACES SALUD 302979",
      "dependencia": "CINVESTAV",
      "siglas": "CINVESTAV",
      "score": 0.23806221712006292
    },
    {
      "numero_procedimiento": "aa-11-l4j-011l4j995-n-257-2024",
      "nombre_procedimiento": "SERVICIO DE AUDITORIA",
      "dependencia": "CINVESTAV",
      "siglas": "CINVESTAV",
      "score": 0.2386015199781356
    },
    {
      "numero_procedimiento": "aa-12-nde-012nde001-n-300-2024",
      "nombre_procedimiento": "AUDITORÍA PROYECTO 27832 EVALUACIÓN DEL EFECTO DE LA INSULINA Y LA METFORMINA SO",
      "dependencia": "INPER",
      "siglas": "INPER",
      "score": 0.2681432148260833
    },
    {
      "numero_procedimiento": "aa-11-l4j-011l4j996-n-48-2025",
      "nombre_procedimiento": "SERVICIOS PROFESIONALES DE AUDITORIA",
      "dependencia": "CINVESTAV",
      "siglas": "CINVESTAV",
      "score": 0.27330803871154785
    },
    {
      "numero_procedimiento": "aa-11-l4j-011l4j997-n-37-2025",
      "nombre_procedimiento": "SERVICIOS PROFESIONALES DE ASESORAMIENTO",
      "dependencia": "CINVESTAV",
      "siglas": "CINVESTAV",
      "score": 0.2735370071486175
    },
    {
      "numero_procedimiento": "aa-12-m7f-012m7f002-n-105-2024",
      "nombre_procedimiento": "PROYECTO IC18097.0 MECANISMOS DE NEUROADAPTACIÓN AL ALCOHOL",
      "dependencia": "INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ",
      "siglas": "INPSIQ",
      "score": 0.27805614471435547
    }
  ]
}